Biotech

All Articles

' Medical intuition' led FDA experts to support Zevra's uncommon condition med

.Zevra Rehabs' uncommon condition medication seems to be on the road to confirmation this autumn aft...

Pfizer takes $230M attacked after axing stopped working DMD genetics therapy

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has actually gone ...

AC Immune sees 'spots' possible in Alzheimer's medicine data

.After greater than two decades of work with neurodegenerative illness, Swiss biotech hvac Immune ca...

GSK loses ph. 2 HPV injection over lack of best-in-class prospective

.GSK has broken up a period 2 human papillomavirus (HPV) injection from its pipe after making a deci...

OS Therapies refiles $6M IPO to fund HER2 medicine, preclinical ADCs

.Operating system Therapies will note on the NYSE American stock swap today through a $6.4 thousand ...

ALX's waning CD47 action fee sends out supply spiraling down

.ALX Oncology's period 2 stomach cancer cells action cost has weakened. After finding its CD47 block...

Ionis centers eye disease coming from aim ats of Roche-partnered possibility after records let down

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has fallen short of desires, moti...

Biogen's chief executive officer said no dangerous sell 2023. He prepares to become strong

.While Biogen's pharma peers are seeking for late-stage resources with little bit of danger, CEO Chr...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Bio has actually been actually a biotech searching for a pipeline after it junked its lead r...

Biogen ignores Denali Alzheimer's collab

.Biogen has actually restored civil rights to an early Alzheimer's health condition plan to Denali T...